Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Revolution Medicines, Inc.

Clinical trials sponsored by Revolution Medicines, Inc., explained in plain language.

Revolution Medicines, Inc. RVMD NASDAQ

Develops targeted therapies for RAS-driven cancers.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 12 Not yet finished but already full! 2 Completed 1

New drug cocktail targets tough lung cancer mutation

Disease control Completed

This phase 2 trial tested a combination of two oral drugs, RMC-4630 and sotorasib, in 47 adults with advanced KRASG12C-mutant non-small cell lung cancer that had progressed after standard treatments. The goal was to see if the combination could shrink tumors. The study is now com…

Phase: PHASE2 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC